# Differences in time to patient access to innovative cancer medicines in six European countries

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/differences-in-time-to-patient-access-to-innovative-cancer-medicines-in-six/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Julie M. Vancoppenolle,Nora Franzen,Simone N. Koole,Valesca P. Retèl,Wim H. van Harten |
| Citations | 22 |
| DOI | 10.1002/ijc.34753 |
| Fields | Economics, Econometrics and Finance |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.34753 |
| OpenAlex ID | https://openalex.org/W4387840705 |
| PMID | 37864395 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Nora Franzen](https://scholariq.org/researchers/nora-franzen/)

## Paper journal

- [International Journal of Cancer](https://scholariq.org/journals/international-journal-of-cancer/)

## Paper primary topic

- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

## Paper topics

- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.